Introduction Emma Walmsley, CEO of GlaxoSmithKline (GSK), has emerged as a leading figure in the pharmaceutical industry, championing innovation and strategic growth. Her leadership comes at a pivotal time when the sector faces both challenges and opportunities, particularly in the wake of the COVID-19 pandemic that has reshaped global health perspectives. GSK’s Innovation Strategy Under